Evantas Biotec Private Limited

Evantas Biotec Private Limited - pharma in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
CIN U24132KA2012PTC064392 Incorporated 14 June 2012 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2022
₹53.7 Lakh
▲ 47% YoY
Net profit · FY 2022
₹34,713
Net margin 0.6%
EBITDA · FY 2022
₹1.04 Lakh
EBITDA margin 1.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings

About Evantas Biotec Private Limited

Data last updated:

Evantas Biotec Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24132KA2012PTC064392. Its GSTIN is 29AADCE0937C1ZX (Karnataka).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Jagadeesh Nanjundaiah (Managing Director) and Janardhan Reddy Bandi.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 191 2nd Stage West Of Chord Road, Bengaluru, Karnataka, India – 560086.

As per the financials filed for FY 2022, the company reported a revenue of ₹53.7 Lakh, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹34,713 (net margin 0.6%) and EBITDA of ₹1.04 Lakh (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over five years.

As per MCA filings, the company has open charges of ₹5 Lakh on record.

Evantas Biotec Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0238267). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24132KA2012PTC064392
Registration Number 064392
Incorporation Date 14 June 2012
ROC Bangalore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0238267

Recognitions & Rankings of Evantas Biotec

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-KR-03-0238267

Contact details

Evantas Biotec Private Limited's registered office is in Bengaluru, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    191 2nd Stage West Of Chord Road, Bengaluru, Karnataka, India – 560086
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Evantas Biotec Private Limited, buy the company report.

Comprehensive company report
Evantas Biotec Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Evantas Biotec is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Evantas Biotec Private Limited, buy the company report.

Financials of Evantas Biotec Private Limited

FY 2022 filings available

Evantas Biotec Private Limited reported revenue of ₹53.7 Lakh (up 47% YoY) for FY 2022.

Revenue · FY 2022
₹53.7 Lakh ▲ 47%
Net profit · FY 2022
₹34,713 margin 0.6%
EBITDA · FY 2022
₹1.04 Lakh margin 1.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 47%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 46%
3 years · compounded
▲ 62%
5 years · compounded
▲ 1%

Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 47% growth in the latest year. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.04 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹34,713
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin1.9%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Evantas Biotec Private Limited, buy the company report.

Board of directors of Evantas Biotec Private Limited

Evantas Biotec has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jagadeesh NanjundaiahManaging Director14 Jun 201214 Years 5 MonthsCurrent
Janardhan Reddy BandiDirector14 Jun 201214 Years 5 MonthsCurrent

Auditor

Evantas Biotec Private Limited is audited by SUBRAMANYA & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
SUBRAMANYA & COFY 2017015298S

Shareholding

The shareholding of Evantas Biotec Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Evantas Biotec Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 Mar 2020100334259Others₹5 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Evantas Biotec Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Evantas Biotec has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AADCE0937C1ZXKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Evantas Biotec Private Limited, buy the company report.

Recent activity

Evantas Biotec Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Nabirasool Ameensab Mamadapur ceased to be Additional Director on 16 May 2019.

AGM
Evantas Biotec Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Evantas Biotec Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
Charges
A charge with Others amounted to Rs. 5.00 Lakh with Charge ID 100334259 was registered on 05 Mar 2020.
Ceased
Nabirasool Ameensab Mamadapur ceased to be Additional Director.
Ceased
Matada Jayappa Aruna ceased to be Director.
Ceased
Bidarakka Sannegowda Sathish ceased to be Director.
Appointed
Jagadeesh Nanjundaiah was appointed as Managing Director.
Appointed
Janardhan Reddy Bandi was appointed as Director.
Incorporation
14 Jun 2012
Evantas Biotec Private Limited was registered on 14 Jun 2012 with Roc Bangalore & aged 14 years 5 months as per MCA records.

Frequently asked questions

Evantas Biotec is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2012 (14+ years old) and is registered under CIN U24132KA2012PTC064392.

Evantas Biotec has 2 current directors:

The latest financial statements of Evantas Biotec on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.

The GSTIN of Evantas Biotec is 29AADCE0937C1ZX, registered in Karnataka.

The CIN (Corporate Identification Number) of Evantas Biotec is U24132KA2012PTC064392. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Evantas Biotec was incorporated on 14 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.

Nabirasool Ameensab Mamadapur ceased to be Additional Director on 16 May 2019. Matada Jayappa Aruna ceased to be Director on 04 Dec 2015. Bidarakka Sannegowda Sathish ceased to be Director on 13 Oct 2015. Evantas Biotec has 5 board changes on record in total.

Yes, Evantas Biotec is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0238267).

The registered office of Evantas Biotec is at 191 2nd Stage West Of Chord Road, Bengaluru, Karnataka, India – 560086.

Evantas Biotec operates in the pharma industry, in the drug formulation and development segment.